TDN injection in Alzheimer's disease rats significantly reversed these changes, restoring the expression of active caspase‐3, Bax and Bcl‐2 to the levels of the control and sham groups (P < .01). The gene discussed is BCL2; the disease is early-onset autosomal dominant Alzheimer disease.